Please ensure Javascript is enabled for purposes of website accessibility
UK Coronavirus Vaccine Prompts Immune Response in Early Test
gvw_ap_news
By Associated Press
Published 5 years ago on
July 20, 2020

Share

LONDON — Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot.

In research published Monday in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55 that lasted at least two months after they were immunized.
British researchers first began testing the vaccine in April in about 1,000 people, half of whom got the experimental vaccine. Such early trials are designed to evaluate safety and see what kind of immune response was provoked, but can’t tell if the vaccine truly protects.
In research published Monday in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55 that lasted at least two months after they were immunized.
“We are seeing good immune response in almost everybody,” said Dr. Adrian Hill, director of the Jenner Institute at Oxford University. “What this vaccine does particularly well is trigger both arms of the immune system,” he said.
Hill said that neutralizing antibodies are produced — molecules which are key to blocking infection. In addition, the vaccine also causes a reaction in the body’s T-cells which help to fight off the coronavirus.
The experimental COVID-19 vaccine caused minor side effects like fever, chills and muscle pain more often than in those who got a control meningitis vaccine.
Hill said that larger trials evaluating the vaccine’s effectiveness, involving about 10,000 people in the U.K. as well as participants in South Africa and Brazil are still underway. Another big trial is slated to start in the U.S. soon, aiming to enroll about 30,000 people.
How quickly scientists are able to determine the vaccine’s effectiveness will depend largely on how much more transmission there is, but Hill estimated they might have sufficient data by the end of the year to decide if the vaccine should be adopted for mass vaccination campaigns.

Hill Said Oxford Has Partnered With Drugmaker AstraZeneca to Produce Their Vaccine Globally

He said the vaccine seemed to produce a comparable level of antibodies to those produced by people who recovered from a COVID-19 infection and hoped that the T-cell response would provide extra protection.
“There’s increasing evidence that having a T-cell response as well as antibodies could be very important in controlling COVID-19,” Hill said. He suggested the immune response might be boosted after a second dose; their trial tested two doses administered about four weeks apart.
Hill said Oxford’s vaccine is designed to reduce disease and transmission. It uses a harmless virus — a chimpanzee cold virus, engineered so it can’t spread — to carry the coronavirus’ spike protein into the body, which should trigger an immune system response.
Hill said Oxford has partnered with drugmaker AstraZeneca to produce their vaccine globally, and that the company has already committed to making 2 billion doses.
“Even 2 billion doses may not be enough,” he said, underlining the importance of having multiple shots to combat the coronavirus.
“There was a hope that if we had a vaccine quickly enough, we could put out the pandemic,” Hill said, noting the continuing surge of infections globally. “I think its going to be very difficult to control this pandemic without a vaccine.”
Numerous countries including Germany, France, the Netherlands, Italy, U.S. and the U.K. have all signed deals to receive hundreds of millions of doses of the vaccine — which has not yet been licensed — with the first deliveries scheduled for the fall. British politicians have promised that if the shot proves effective, Britons will be the first to get it.
Chinese researchers also published a study on their experimental COVID-19 vaccine in the Lancet on Monday, using a similar technique as the Oxford scientists. They reported that in their study of about 500 people, an immune response was detected in those who were immunized. But they noted that because the participants weren’t exposed to the coronavirus afterwards, it wasn’t possible to tell if they were protected from the disease.

Nearly Two Dozen Potential Vaccines Are in Various Stages of Human Testing Worldwide

CanSino Biologics’ vaccine is made similarly to Oxford’s except the Chinese shot is made with a human cold virus, and the study showed people whose bodies recognized it didn’t get as much of the presumed COVID-19 benefit. Still, China’s government already gave special approval for the military to use CanSino’s vaccine while it explores final-stage studies.

British officials said Monday they had also signed a deal to buy 90 million doses of experimental COVID-19 vaccines being developed by the pharmaceutical giant Pfizer and others.
In an accompanying editorial, Naor Bar-Zeev and William Moss of the Johns Hopkins Bloomberg School of Public Health called both the Oxford and Chinese results “encouraging” but said further judgment should wait until the vaccine is tested on much bigger populations.
Bar-Zeev and Moss also called for any effective COVID-19 vaccine to be distributed equitably around the world.
“Global planning is underway, but should be underpinned and informed by specific local realities,” they wrote. “Only this way can these very encouraging first earlyphase randomised trial results yield the global remedy for which we all yearn.”
Last week, American researchers announced that the first COVID-19 vaccine tested there boosted people’s immune systems just as scientists had hoped and the shots will now enter the final phase of testing. That vaccine, developed by the National Institutes of Health and Moderna, produced the molecules key to blocking infection in volunteers who got it, at levels comparable to people who survived a COVID-19 infection.
Nearly two dozen potential vaccines are in various stages of human testing worldwide, with a handful entering necessary late-stage testing to prove effectiveness.
British officials said Monday they had also signed a deal to buy 90 million doses of experimental COVID-19 vaccines being developed by the pharmaceutical giant Pfizer and others.
In a statement, the British government said it had secured access to a vaccine candidate being developed by Pfizer and BioNTech, in addition to another experimental vaccine researched by Valneva.

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Newsom Wants to Bypass Trump Tariffs With Direct CA Trade Deals

DON'T MISS

Markets Plunge With S&P 500 Down 6% and Dow Down 2,200 After China Retaliates

DON'T MISS

Fresno Police Searching for Missing 12-Year-Old Girl

DON'T MISS

Madera Community College Unveils New Multicultural and Veterans Center

DON'T MISS

Fusion Energy Race Is On. Two Local Lawmakers Want California to Lead the Way

DON'T MISS

Saturday’s Spring Fest to Showcase Free, Low-Cost Activities for Fresno Kids

DON'T MISS

LA County Reaches $4 Billion Agreement to Settle Sexual Abuse Claims at Juvenile Facilities

DON'T MISS

Fresno Man Sentenced to 14 Years in Prison for Deadly Marijuana DUI Crash

DON'T MISS

Judge Says US Must Return Maryland Man Who Was Mistakenly Deported to El Salvador Prison

DON'T MISS

These Fresno First-Graders Are Topping Their Peers in Reading

UP NEXT

The NBA’s Playoff Chase Enters Its Final Days. Here’s a Look at What’s Happening

UP NEXT

USC’s JuJu Watkins Named AP Player of the Year After Historic Sophomore Season

UP NEXT

Dodgers’ Freddie Freeman Lands on Injured List Following Fall in His Shower at Home

UP NEXT

How Trump’s Latest Tariffs Could Affect Your Wallet

UP NEXT

Curry Scores 37 Points and Warriors Beat Lakers in a Potential First-Round Playoff Preview

UP NEXT

Israeli Military Orders New Evacuation of Gaza City Neighborhoods

UP NEXT

China Halts Approvals for New US Investment Projects

UP NEXT

Measles Spreads to Central Texas; 5 States Have Active Outbreaks

UP NEXT

Startup Offers Controversial Microplastic Blood Cleansing Treatment

UP NEXT

Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6

Madera Community College Unveils New Multicultural and Veterans Center

3 hours ago

Fusion Energy Race Is On. Two Local Lawmakers Want California to Lead the Way

3 hours ago

Saturday’s Spring Fest to Showcase Free, Low-Cost Activities for Fresno Kids

3 hours ago

LA County Reaches $4 Billion Agreement to Settle Sexual Abuse Claims at Juvenile Facilities

4 hours ago

Fresno Man Sentenced to 14 Years in Prison for Deadly Marijuana DUI Crash

4 hours ago

Judge Says US Must Return Maryland Man Who Was Mistakenly Deported to El Salvador Prison

4 hours ago

These Fresno First-Graders Are Topping Their Peers in Reading

5 hours ago

Fresno Burial Ceremony to Honor Five Abandoned Babies Set for Saturday

5 hours ago

Visalia Man Arrested for Soliciting Sex From Minor in Kingsburg

6 hours ago

Camalah Saleh Cruises to Win in Stormy Fresno State Student Elections

7 hours ago

Newsom Wants to Bypass Trump Tariffs With Direct CA Trade Deals

Gov. Gavin Newsom on Friday asked exporting countries worldwide to spare California their retaliatory tariffs, saying he plans to pursue dir...

2 hours ago

2 hours ago

Newsom Wants to Bypass Trump Tariffs With Direct CA Trade Deals

Specialist Anthony Matesic works on the floor of the New York Stock Exchange, Friday, April 4, 2025. (AP/Richard Drew)
2 hours ago

Markets Plunge With S&P 500 Down 6% and Dow Down 2,200 After China Retaliates

Fresno police are searching for Unique Hernandez, 12, last seen on Friday, April 4, 2025, near Inyo Street and Maple Avenue, wearing all black clothing and carrying a black backpack. (Fresno PD)
2 hours ago

Fresno Police Searching for Missing 12-Year-Old Girl

3 hours ago

Madera Community College Unveils New Multicultural and Veterans Center

3 hours ago

Fusion Energy Race Is On. Two Local Lawmakers Want California to Lead the Way

3 hours ago

Saturday’s Spring Fest to Showcase Free, Low-Cost Activities for Fresno Kids

4 hours ago

LA County Reaches $4 Billion Agreement to Settle Sexual Abuse Claims at Juvenile Facilities

Antonio de Jesus Orozco Montes Deoca, 30, was sentenced on Friday, March 4, 2025, to 14 years and 8 months in prison for a deadly marijuana DUI crash in 2022 that killed one woman and injured four others. (GV Wire Composite)
4 hours ago

Fresno Man Sentenced to 14 Years in Prison for Deadly Marijuana DUI Crash

Help continue the work that gets you the news that matters most.

Search

Send this to a friend